HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

pirozadil

structure

Also Known As:

2,6-pyridinediyldimethylene bis(3,4,5-trimethoxybenzoate)

Networked: 7 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - pirozadil: 7

Related Diseases

1.	Hyperlipoproteinemias 01/01/1989 - "With the goal to evaluate the long term efficacy and tolerance of pirozadil, 20 patients with hypercholesterolemia (type II a hyperlipoproteinemia) received this drug for 4.5 years. " 03/01/1982 - "[Single-blind study of the efficacy of pirozadil versus alufibrate in the treatment of primary hyperlipoproteinemias]." 03/01/1982 - "Pirozadil and alufibrate are compared by a single-blind study over two groups 20 patients with primary hyperlipoproteinemia. "
2.	Hypercholesterolemia 01/01/1989 - "Taken as a whole, these results reinforce the usefulness of pirozadil in treating patients with hypercholesterolemias." 01/01/1989 - "With the goal to evaluate the long term efficacy and tolerance of pirozadil, 20 patients with hypercholesterolemia (type II a hyperlipoproteinemia) received this drug for 4.5 years. " 03/01/1989 - "Six patients (four women and two men) with mild to moderate hypercholesterolemia, but with no clinical evidence of the disease being monogenic familial hypercholesterolaemia and who, over the previous 3 months on a rigidly controlled hypolipidaemic diet therapy, showed no reduction in plasma cholesterol levels, were recruited into a study to assess the metabolic effects of Pirozadil, a new nicotinic acid derivative. "
3.	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/01/1989 - "[Clinical evaluation of pirozadil, administered continuously over four and a half years, in patients with hyperlipoproteinemia type IIa]." 09/01/1987 - "The results obtained suggest the beneficial effect of pirozadil on serum lipids in patients with Type IIa hyperlipoproteinemia." 09/01/1987 - "Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia."
4.	Atherosclerosis 05/16/1982 - "[Clinical trial of a new drug for the treatment of atherosclerosis: pirozadil (722-D) (author's transl)]."
5.	Myocardial Ischemia (Ischemic Heart Diseases) 05/01/1982 - "[A double blind study of the new hypolipidemic agent pirozadil (722-D) using patients with ischemic heart disease (author's transl)]."

Related Drugs and Biologics

1.	alfibrate
2.	Niacin (Nicotinic Acid)
3.	Cholesterol
4.	Xanthinol Niacinate (Xavin)
5.	Nicotinyl Alcohol (Pyridylcarbinol)
6.	Lipoproteins (Lipoprotein)
7.	Lipids
8.	Apolipoproteins
9.	Hypolipidemic Agents (Antihyperlipidemics)

Related Therapies and Procedures

1.	Diet Therapy (Therapy, Diet)